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A STUDY ON HYPERCOAGULABILTIY USING HEPARIN 
LOADING TEST 
ORHAN N U R I U L U T I N , M.D.* and D I M I T R I SESTAKOF, M.D.** 
During recent years increasing attention has been paid to the role of hyper-
coagulability in the pathogenesis of arteriosclerosis and intravascular thrombosis. 
Since there ai-e several reviews and publications on this extensive research field, we 
shall not discuss the literature in detail. 
In order to reveal "hypercoagulability" many workers introduced several methods. 
We suggested".'' "heparin loading test" for this purpose. We are going to discuss in 
this paper the results which we obtained using this method in the cases of arterio-
sclerosis, ischaemic-heart disease, myocardial infarction, essential hypertension and 
thrombophlebitis. 
METHODS A N D MATERIAL 
The coagulation time was measured with the method of Lee and White^ one-
stage prothrombin time with the method of Quick", antithrombin time with the 
method of Studer'^  and Winterstein, and heparin clotting time with the method of 
Rosenthal'" were performed. The thromboplastin generation test was used according 
to Biggs' and Douglas. 
The heparin loading test according to Ulutin"-" and Sestakof was performed as 
follows: 100 mg. heparinf was given intravenously before, and 15, 30, 60, 90, 120, 
180, and 240 minutes later venous blood was obtained and thromboplastin formation 
was followed by means of thromboplastin generation test of Biggs and Douglas. 
We used the serum after 4 hours of clotting incubated in 37° C waterbath. 
In the simplified heparin loading test blood samples were taken before heparin 
injection, 20 and 60 minutes after. 
Cholesterol and total lipid were determined and lipidogram was performed. 
These experiments were made on ten normal subjects and twenty-two patients. 
RESULTS 
Antithrombin time shortened in 7 cases out of 12, and in 5 cases out of 14 
heparin clotting time diminished. We noticed also that in 14 cases out of 22 the thrombo-
plastin curve was higher than the normal with the thromboplastin generation test. With 
heparin loading test we observed the following results; in 7 out of 10 normal subjects the 
antithromboplastic effect of heparin continued 90 - 180 minutes (Fig. I ) . In three 
subjects out of ten the mild antithromboplastic effect lasted 60 - 90 minutes. 
In 16 cases out of 22 the antithromboplastic effect of heparin lasted 15-30 
minutes and at 60 - 90 minutes we obtained normal curve (Fig. 2). 
However, in six cases antithromboplastic effect of heparin could not be found 
in the blood even 15 minutes after the injections (Fig. 3). 
*Division of Hematology and Department of Laboratories, Division of Coagulation. 
**Second Internal Chnic, Istanbul University, Istanbul, Turkey. 
tLiquemin "Roche" and Heparin Vitrum were used. 
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Figure 1 
DISCUSSION 
Biggs^ Douglas and MacFarlane in 1953 have shown that heparin inhibits the 
formation of blood thromboplastin. In 1954 MacMillan' and Brown confirmed the 
antithromboplastic effect of heparin, and they also observed that intravenous heparin 
causes a defect in serum fraction. Douglas" in 1956 showed that in the blood which 
was taken after injecting heparin AHG, Factor V and prothrombin were not consumed. 
In 1957 we confirmed" that in the blood taken after heparin injections the 
generation of thromboplastin was inhibited, and we pointed out that the continuation of 
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antithromboplastic effect of heparin was different in normal persons and in some patients. 
In several patients having arteriosclerosis, ischaemic heart disease and thromboplebitis 
the antithromboplastic effect of heparin lasted for a short time or did not appear at all. 
In other words, heparin was either consumed or neutralized rapidly. 
In cases showing hypercoagulability, according to the heparin loading test, after 
three or six months of strict low-fat diet and anticoagulant treatment, hypercoagulability 
decreased or became normal" (50 mgs heparin twice weekly intravenously). In 
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these so-called hypercoagulability cases cholesterol and blood lipid level increased. 
Lipidogram showed a decrease in A lipids and an increase in B lipids. 
In 1957 McDonald''* and Edgill in such cases obtained a shortening of Stypven 
time, an increase of platelet stickiness and a higher thromboplastin curve in thrombo-
plastin generation test. Authors dwell upon the relation between the increase of 
cholesterol level and platelet-stickiness. 
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In 1957 Kirk ' and others and in 1958 Berenson' have shown that vascular 
endothelium is lined with a heparin-like mucopolysaccharides, and this substance has 
an anticoagulant activity. 
In 1958 O'Brien"." showed that heparin influenced the Christmas factor. According 
to author, heparin has affinity for platelets, the Christmas factor and lipoproteins. On 
the other hand Mustard'-'" showed that in patients with arteriosclerosis activity of 
the Christmas factor was increased. 
In our opinion there is a close relation between the resuhs of the heparin loading 
test and recent findings in the literature. 
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